Patent · US Active

Modified vaccinia virus ankara for the vaccination of neonates

US8372622B2 · kind B2 · utility

11Cited by

25References

20Claims

0Family size

Assignee

Bavarian Nordic A/S · DK

Inventors

Mark Suter · Luzern, CH
Sabine Vollstedt · Zürich, CH
Paul Chaplin · Munich, DE

Key dates

Filing date	Jan 14, 2011
Grant date	Feb 12, 2013
Priority date	—
Expiry date	Feb 15, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2710/24143
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates inter alia to a method for inducing a long-term protection in an animal against foreign antigens and tumor antigens comprising the step of administering to the animal at least one factor selected from type I interferons and Flt-3, and to a method for inducing a long-term increase of the number of dendritic cells in an animal comprising the step of administering to the animal a factor selected from type I interferon and Flt-3 and to a method of inducing or enhancing the maturation and/or for the activation of the immune system of an animal comprising the step of administering to the animal a factor selected from type I interferon and Flt-3.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.